Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Long-COVID has diverse, long-term health impacts, especially in young people.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Neem is highly beneficial for health and beauty with no major side effects.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

COVID-19 vaccination may trigger lupus in some people.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

LncRNA MTC boosts growth of goat skin cells, improving cashmere quality.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

New understanding and treatments for hair loss are improving, but more research is needed.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

COVID-19 can cause skin problems in children.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

COVID-19 may harm male fertility and damage the reproductive system.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Possible link between androgens and COVID-19 severity; more research needed.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.